Skip to main content

We’ve updated our Terms & Conditions and Privacy Policy. By using this site, you agree to these terms.

Geisinger becomes the first member of Risant Health

Focus on illness that affects one million Americans

FOR IMMEDIATE RELEASE:

DANVILLE, PA – Geisinger investigator Janet Robishaw, Ph.D., has received a $1.5 million grant from the National Institutes of Health to study a key signaling pathway that is dysfunctional in Parkinson’s disease.

In the United States alone, this disorder affects one million patients who experience a host of motor symptoms, including tremor, general reduction voluntary movements (bradykinesia), and rigidity.

For Parkinson’s patients and their families, the quality of life is greatly reduced and the economic impact is estimated at $25 billion per year. Current treatment options show limited effectiveness. Although dopamine replacement therapy improves the motor symptoms, prolonged treatment often produces uncontrolled movements (dyskinesia) and altered intellectual functions.

By capitalizing on her discovery of a new mechanism to regulate movement, Dr. Robishaw said the goal of this study is to develop a more targeted, effective treatment for this debilitating disorder.

“Our finding also has important implications for treatment for learning disorders and addictive behaviors,” Dr. Robishaw, associate director and senior scientist at Geisinger Health System’s Weis Center for Research, said.

Identifying mechanism-based diagnoses and treatments represent dual goals of the precision medicine initiative instituted by the Geisinger learning health system to improve the overall health of affected patients.

About Geisinger
Geisinger is among the nation’s leading providers of value-based care, serving 1.2 million people in urban and rural communities across Pennsylvania. Founded in 1915 by philanthropist Abigail Geisinger, the non-profit system generates $10 billion in annual revenues across 134 care sites - including 10 hospital campuses, and Geisinger Health Plan, with 600,000 members in commercial and government plans. The Geisinger College of Health Sciences educates more than 5,000 medical professionals annually and conducts more than 1,400 clinical research studies. With 26,000 employees, including 1,600 employed physicians, Geisinger is among Pennsylvania’s largest employers with an estimated economic impact of $14 billion to the state’s economy. On March 31, 2024, Geisinger became the first member of Risant Health, a new nonprofit charitable organization created to expand and accelerate value-based care across the country.  Learn more at geisinger.org or connect with us on Facebook, Instagram, LinkedIn and X.

 
Content from General Links with modal content